Abstract
Medication adherence is highly predictive of health outcomes across chronic conditions, particularly HIV/AIDS. Depression is consistently associated with worse adherence, yet few studies have sought to understand how depression relates to adherence. This study tested three components of behavioral depression theory—goal-directed activation, positive reinforcement, and environmental punishment—as potential indirect effects in the relation between depressive symptoms and medication nonadherence among low-income, predominantly African American substance users (n = 83). Medication nonadherence was assessed as frequency of doses missed across common reasons for nonadherence. Non-parametric bootstrapping was used to evaluate the indirect effects. Of the three intermediary variables, there was only an indirect effect of environmental punishment; depressive symptoms were associated with greater nonadherence through greater environmental punishment. Goal-directed activation and positive reinforcement were unrelated to adherence. Findings suggest the importance of environmental punishment in the relation between depression and medication adherence and may inform future intervention efforts for this population.
Similar content being viewed by others
References
Airoldi, M., Zaccarelli, M., Bisi, L., Bini, T., Antinori, A., Mussini, C., et al. (2010). One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Preference and Adherence, 4, 115.
Asch, S. M., Kilbourne, A. M., Gifford, A. L., Burnam, M. A., Turner, B., Shapiro, M. F., et al. (2003). Underdiagnosis of depression in HIV. Journal of General Internal Medicine, 18, 450–460.
Aversa, S. L., & Kimberlin, C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29, 207–219.
Benassi, V. A., Sweeney, P. D., & Dufour, C. L. (1988). Is there a relation between locus of control orientation and depression? Journal of Abnormal Psychology, 97, 357–367.
Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G., Richardson, M. A., & Keane, T. M. (2007). Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs, 21, 942–955.
Binford, M. C., Kahana, S. Y., & Altice, F. L. (2012). A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports, 9, 287–312.
Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721.
Bogart, L. M., Wagner, G. J., Galvan, F. H., & Klein, D. J. (2010). Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Annals of Behavioral Medicine, 40, 184–190.
Burack, J. H., Barrett, D. C., Stall, R. D., Chesney, M. A., Ekstrand, M. L., & Coates, T. J. (1993). Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association (JAMA), 270, 2568–2573.
Carvalho, J. P., Gawrysiak, M. J., Hellmuth, J. C., McNulty, J. K., Magidson, J. F., Lejuez, C. W., et al. (2011). The Reward Probability Index (RPI): Design and validation of a scale measuring access to environmental reward. Behavior Therapy, 42, 249–262.
Chander, G., Himelhoch, S., Fleishman, J. A., Hellinger, J., Gaist, P., Moore, R. D., et al. (2009). ART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care, 21, 655–663.
Chesney, M. (2003). Adherence to ART regimens. AIDS Patient Care and STDs, 17, 169–177.
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in the HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12, 255–266.
Crum, N. F., Riffenburgh, R. H., Wegner, S., Agan, B. K., Tasker, S. A., Spooner, K. M., et al. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes (JAIDS), 41, 194–200.
Daughters, S. B., Magidson, J. F., Schuster, R. M., & Safren, S. A. (2010). ACT HEALTHY: A combined cognitive-behavioral depression and medication adherence treatment for HIV-infected substance users. Cognitive and Behavioral Practice, 17, 309–321.
DiIorio, C., McCarty, F., Depadilla, L., Resnicow, K., Holstad, M. M., Yeager, K., et al. (2009). Adherence to antiretroviral medication regimens: A test of a psychosocial model. AIDS and Behavior, 13, 10–22.
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. JAIDS, 18, 117–125.
Evans, S., Ferrando, S. J., Rabkin, J. B., & Fishman, B. (2000). Health locus of control, distress, and utilization of protease inhibitors among HIV-positive men. Journal of Psychosomatic Research, 49, 157–162.
Ferster, C. B. (1973). A functional analysis of depression. American Psychologist, 28, 857–870.
First, M. B., & Gibbon, M. (2004). Structured clinical interview for DSM-IV axis I disorders (SCID-I) and the structured clinical interview for DSM-IV Axis II disorders (SCID-II). In M. J. Hilsenroth, & D. L. Segal (Eds.), Comprehensive handbook of psychological assessment, Vol. 2: Personality assessment. Hoboken, NJ: Wiley.
Fritz, M. S., & MacKinnon, D. P. (2007). Required sample size to detect the mediated effect. Psychological Science, 18, 233–239.
García, D. O. P., Knobel, H., Carmona, A., Guelar, A., López-Colomés, J. L., & Caylà, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. JAIDS, 30, 105–110.
Gifford, A., Bormann, J., & Shively, M. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. JAIDS, 23, 386–395.
Gonzalez, J., Batchelder, A. W., Psaros, C., & Safren, S. (2011a). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS, 58, 181–187.
Gonzalez, J. S., Psaros, C., Batchelder, A., Applebaum, A., Newville, H., & Safren, S. (2011b). Clinician-assessed depression and ART adherence in HIV-infected individuals in methadone maintenance treatment. Annals of Behavioral Medicine, 42, 120–126.
Gore-Felton, C., & Koopman, C. (2008). Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosomatic Medicine, 70, 569–574.
Hayes, A. F. (2009). Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Communication Monographs, 76, 408–420.
Hicks, P. L., Mulvey, K. P., Chander, G., Fleishman, J. A., Josephs, J. S., Korthuis, P. T., et al. (2007). The impact of illicit drug use and substance abuse treatment on adherence to ART. AIDS Care, 19, 1134–1140.
Hiroto, D. S. (1974). Locus of control and learned helplessness. Journal of Experimental Psychology, 102, 187–193.
Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13, 185–197.
Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., et al. (2008). Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. JAIDS, 27, 384–390.
Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA, 285, 1466–1474.
Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16, 199–211.
Kalichman, S. C., Amaral, C. M., Swetzes, C., Jones, M., Macy, R., Kalichman, M. O., et al. (2009). A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care, 8, 367–374.
Kanter, J. W., Mulick, P. S., Busch, A. M., Berlin, K. S., & Martell, C. R. (2007). The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment, 29, 191–202.
Kanter, J. W., Rusch, L. C., Busch, A. M., & Sedivy, S. K. (2009). Validation of the Behavioral Activation for Depression Scale (BADS) in a community sample with elevated depressive symptoms. Journal of Psychopathology and Behavioral Assessment, 31, 36–42.
Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70, 539–545.
Leserman, J., Petitto, J. M., Gu, H., Gaynes, B. N., Barroso, J., Golden, R. N., et al. (2002). Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychological Medicine, 32, 1059–1073.
Lewinsohn, P. M. (1974). A behavioral approach to depression. In R. M. Friedman & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. New York: Wiley.
Lewinsohn, P. M., & Graf, M. (1973). Pleasant activities and depression. Journal of Consulting and Clinical Psychology (JCCP), 41, 261–268.
Lewinsohn, P. M., & Libet, J. (1972). Pleasant events, activity schedules, and depressions. Journal of Abnormal Psychology, 79, 291–295.
Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., & Sanandaji, S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.
Magidson, J. F., Blashill, A. J., Safren, S. A., & Wagner, G. J. (in press). Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: A longitudinal mediation analysis. AIDS and Behavior.
Magidson, J. F., Seitz-Brown, C. J., Safren, S. A., & Daughters, S. B. (2014). Implementing behavioral activation and Life-Steps for depression and HIV medication adherence in a community health center. Cognitive Behavioral Practice, 21, 386–403.
Maier, W., & Philipp, M. (1985). Improving the assessment of severity of depressive states: A reduction of the Hamilton Depression Rating Scale. Pharmacopsychiatry, 18, 114–115.
Malebranche, D. J., Peterson, J. L., Fullilove, R. E., & Stackhouse, R. W. (2004). Race and sexual identity: Perceptions about medical culture and healthcare among Black men who have sex with men. Journal of the National Medical Association, 96, 97–107.
Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 1242–1257.
Maxwell, S. E., & Cole, D. A. (2007). Bias in cross-sectional analyses of longitudinal mediation. Psychological Methods, 12, 23–44.
McIntyre, R. S., Konarski, J. Z., Mancini, D. A., Fulton, K. A., Parikh, S. V., Grigoriadis, S., Grupp, L. A., & Kennedy, S. H. (2005). Measuring the severity of depression and remission in primary care: Validation of the HAMD-7 scale. Canadian Medical Association Journal, 173(11), 1327–1334.
Newcomb, M. D., & Harlow, L. L. (1986). Life events and substance use among adolescents: Mediating effects of perceived loss of control and meaninglessness in life. Journal of Personality and Social Psychology, 51, 564.
O’Cleirigh, C., Ironson, G., & Smits, J. A. (2007). Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? Behavior Therapist, 38, 314–323.
Pablos-Méndez, A., Knirsch, C. A., Barr, R. G., Lerner, B. H., & Frieden, T. R. (1997). Nonadherence in tuberculosis treatment: Predictors and consequences in New York City. The American Journal of Medicine, 102, 164–170.
Palmer, N. B., Salcedo, J., Miller, A. L., Winiarski, M., & Arno, P. (2003). Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care and STDs, 17, 635–644.
Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, 36, 717–731.
Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods, 40, 879–891.
Roberts, K. J. (2000). Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs, 14, 155–168.
Rotter, J. B. (1966). Generalized expectancies for internal versus external control of reinforcement. Psychological Monographs: General and Applied, 80, 1–28.
Rotter, J. B. (1975). Some problems and misconceptions related to the construct of internal versus external control of reinforcement. JCCP, 43, 56–67.
Ryan, G. W., & Wagner, G. J. (2003). Pill taking ‘routinization’: A critical factor to understanding episodic medication adherence. AIDS Care, 15, 795–806.
Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. JCCP, 80, 404–415.
Schlenk, E. A., & Hart, L. K. (1984). Relationship between health locus of control, health value, and social support and compliance of persons with diabetes mellitus. Diabetes Care, 7, 566–574.
Shah, S. S., McGowan, J. P., Smith, C., Blum, S., & Klein, R. S. (2002). Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clinical Infectious Diseases, 35, 1238–1243.
Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29, 117–127.
Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245.
Stanton, A. L. (1987). Determinants of adherence to medical regimens by hypertensive patients. Journal of Behavioral Medicine, 10, 377–394.
Tabachnik, B. G., & Fidell, L. S. (2007). Using multivariate statistics. Boston: Pearson.
Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle-, and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports, 11, 291–307.
Wagner, G. J., Goggin, K., Remien, R. H., Rosen, M. I., Simoni, J., Bangsberg, D. R., et al. (2011). A closer look at depression and its relationship to HIV antiretroviral adherence. Annals of Behavioral Medicine, 42, 352–360.
Wagner, G. J., & Ryan, G. W. (2004). Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDs, 18, 385–393.
Walkup, J., Wei, W., Sambamoorthi, U., & Crystal, S. (2008). Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatric Quarterly, 79, 43–53.
Wallston, K. A., Wallston, B. S., & DeVellis, R. (1978). Development of the multidimensional health locus of control (MHLC) scales. Health Education and Behavior, 6, 160–170.
Warner, E. A., Greene, G. S., Buchsbaum, M. S., Cooper, D. S., & Robinson, B. E. (1998). Diabetic ketoacidosis associated with cocaine use. Archives of Internal Medicine, 158, 1799.
Acknowledgments
This study was supported by Grants R01DA022974 (PI: Daughters) and R36DA034513 (PI: Magidson). Dr. Magidson’s work on this manuscript was also supported by T32MH093310 (PIs: Henderson and Fricchione). Dr. Safren is supported by Grant K24MH094214.
Conflict of interest
Jessica F. Magidson, Alyson Listhaus, C.J. Seitz-Brown, Steven A. Safren, C.W. Lejuez, and Stacey B. Daughters declare that they have no conflict of interest.
Human and animal rights and informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magidson, J.F., Listhaus, A., Seitz-Brown, C.J. et al. Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?. J Behav Med 38, 337–347 (2015). https://doi.org/10.1007/s10865-014-9606-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-014-9606-1